News

Dangerous Prescription Drugs New Investigation Explores Potential Link Between Ozempic and Vision Loss

A new investigation from researchers at the University of Utah points to a possible cause of serious eye problems in people using Ozempic and similar drugs. The research, published last month, suggested that rapid blood sugar changes from semaglutide or tirzepatide could lead to eye problems. The researchers evaluated nine…

February 19, 2025

Hearing Key to Completion of J&J Talc Settlement Gets Underway

February 18, 2025
Baby Formula Defendants Seek Summary Judgment as Bellwether Trial Nears

February 14, 2025
Here Are the Groups Fighting Against J&J’s Talc Settlement

February 11, 2025
Depo-Provera Lawsuits Consolidated into Florida-Based MDL in Major Step for Litigation

February 7, 2025
Why People Are Filing Oxbryta Lawsuits: A Q&A With Attorney Laura Baughman

February 6, 2025
40 Hair Relaxer Lawsuits to be Considered for Bellwether Trials

February 4, 2025
Wildfire Suppressants May Have Released Toxic Metals into the Environment

January 28, 2025
Paraquat Bellwether Trial Date Set for October

January 28, 2025

Drugwatch is located at:
1 South Orange Ave, Suite 201, Orlando, FL 32801

The information on this website is proprietary and protected. It is not a substitute for advice, diagnosis, treatment and other oversight responsibilities for disease processes by a credentialed physician. Any unauthorized or illegal use, copying or dissemination will be prosecuted. Please read our disclaimer for more information about our website.

Drugwatch.com partners with law firms. This website and its content may qualify as attorney advertising. Prior results do not predict a similar outcome. For more information, visit our partners page.

Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.

If you would like to speak with a Drugwatch representative, please call 888-645-1617